Iniciar sesión

Se requiere una suscripción a JoVE para ver este contenido. Inicie sesión o comience su prueba gratuita.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The protocol summarizes the best practices to minimize microbial bioburden in a cleanroom environment and includes strategies such as environmental monitoring, process monitoring, and product sterility testing. It is relevant for manufacturing and testing facilities that are required to meet current good tissue practice standards and current good manufacturing practice standards.

Abstract

A well-validated and holistic program that incorporates robust gowning, cleaning, environmental monitoring, and personnel monitoring measures is critical for minimizing the microbial bioburden in cellular therapy manufacturing suites and the corresponding testing laboratories to ensure that the facilities are operating in a state of control. Ensuring product safety via quality control measures, such as sterility testing, is a regulatory requirement for both minimally manipulated (section 361) and more than minimally manipulated (section 351) human cells, tissues, and cellular and tissue-based products (HCT/Ps). In this video, we provide a stepwise guide for how to develop and incorporate the best aseptic practices for operating in a cleanroom environment, including gowning, cleaning, staging of materials, environmental monitoring, process monitoring, and product sterility testing using direct inoculation, provided by the United States Pharmacopeia (USP<71>) and the National Institutes of Health (NIH) Alternative Sterility Testing Method. This protocol is intended as a reference guide for establishments expected to meet current good tissue practices (cGTP) and current good manufacturing practices (cGMP).

Introduction

Implementing a strong microbial monitoring program through environmental monitoring (EM), process monitoring, and product sterility testing is a regulatory requirement for current good tissue practices (cGTP) and current good manufacturing practices (cGMP) in cellular therapy laboratories1. Additionally, the United States Food and Drug Administration (FDA) expects that the laboratory performing the quality control (QC) testing of the product should also employ facilities and controls comparable to those used for aseptic filling operations2.

This protocol has four main sections: 1) Aseptic pra....

Protocol

1. Aseptic practices

  1. Personnel gowning for a cleanroom space
    NOTE: This procedure is based on initial gowning in an unclassified space, followed by entry into an International Organization for Standardization (ISO) 8 area and then an ISO7 area. This procedure is relevant for laboratories attempting to convert existing space into a cleanroom function. Ideally, all initial gowning would occur in an ISO8 classified space (not in an unclassified space).
    1. Secure loose hair. Wash .......

Representative Results

The expected results are described in Table 1. The EM data should be reviewed and followed up with an appropriate investigation and response to action, alert, or ISO limit excursions. If an excursion occurs for non-viable particles, one should proceed as per ISO 14644-Annex A, sec A.5.57. If the excursion can be attributed to an immediately identifiable abnormal occurrence, the original sampling results should be documented, a note should be added to disregard the original results.......

Discussion

There are several critical areas in this protocol, including the maintenance of aseptic technique and unidirectional airflow within cleanrooms and the BSCs. Best practices include moving slowly and deliberately to minimize turbulence. Aseptic manipulations should be performed from the side of the product, not from above. Closed system processing and the use of terminally sterilized raw materials are recommended. Speaking in critical areas and leaning against walls or equipment should be avoided. Similarly, unnecessary to.......

Acknowledgements

This work was supported by the Intramural Research Program of the National Institutes of Health Clinical Center. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.

....

Materials

NameCompanyCatalog NumberComments
20-25°C IncubatorLab preference
30-35°C IncubatorLab preference
Alcohol-based hand sanitizerLab preference
BacT/ALERT Dual-T instrumentBioMerieux Industry
Beard coverLab preference
Biosafety cabinet (BSC)Lab preference
Cleanroom shoesLab preference
Fluidthioglycollate medium (FTM)Hardy Diagnostics U84USP
Handheld cleaning mopContec2665LF
Hypodermic needleLab preference
iFA+ BacT/ALERT bottleBiomerieux412990
iFN+ BacT/ALERT bottleBiomerieux412991
Isokinetic headLab preference
Laser particle counterTSI Incorporated9500-01
LpH IIISteris1S16CX
MirrorLab preference
Non-sterile bouffantLab preference
Non-sterile glovesLab preference
Non-sterile shoe coversLab preference
Non-sterile sleeve coversLab preference
ParafilmLab preference
Peridox RTUContecCR85335IR
Plastic bagLab preference
Sabouraud Dextrose Agar with Lecithinase and Tween (SABLT)Hardy Diagnostics P595USP, irradiated
Sabouraurd Dextrose Agar (SAB)Hardy Diagnostics W565USP, irradiated
Safety glassesLab preference
Scrubs (top and bottom)Lab preference
Spor-Klenx RTUSteris6525M2
Sterile 70% isopropyl alcohol (IPA)Decon CiDehol8316
Sterile alcohol wipeLab preference
Sterile boot coversKimberly ClarkCat# varies based on size
Sterile coverallsKimberly ClarkCat# varies based on size
Sterile face maskLab preference
Sterile glovesLab preference
Sterile hoodKimberly ClarkCat# varies based on size
Sterile low-lint wipesTexwipeTX3210
Sterile mop cleaning padsContecMEQT0002SZ
Sterile sleeve coversKimberly Clark36077
Sterile spreading rodFisher Scientific14665231
Sterile syringeLab preference
Tacky matsLab preference
Tryptic Soy Agar (TSA)Hardy Diagnostics W570RUSP, irradiated
Tryptic Soy Agar with Lecithinase and Tween (TSALT)Hardy Diagnostics P520RUSP, irradiated
Tryptic Soy Broth (TSB)Hardy Diagnostics U46USP
TubingLab preference
Vesphene IIISteris1S15CX
Viable air samplerHardy Diagnostics BAS22K
VortexLab preference

References

  1. Cundell, T., Atkins, J. W., Lau, A. F. Sterility testing for hematopoietic stem cells. Journal of Clinical Microbiology. , (2023).
  2. United States Food and Drug Administration. Guidance for Industry. S....

Explore More Articles

Microbial ControlMicrobial MonitoringCleanroom EnvironmentsCellular TherapiesClinical MicrobiologySterility TestingCGMPCulture based MethodsRegulatory RequirementsRisk based ApproachEnd user ValidationGowningCleaningEnvironmental MonitoringPersonnel MonitoringMicrobial BioburdenQuality ControlSterility TestingAseptic PracticesUSPCBER

This article has been published

Video Coming Soon

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados